Algoquant Fintech to List Entire Equity Capital on NSE from January 6; 28.11 Crore Shares to Be Admitted for Trading

1767513464538.webp
Gandhinagar, January 4, 2026
Algoquant Fintech Limited (BSE: 505725) has announced that its entire issued, subscribed and fully paid-up equity share capital comprising 28,10,96,028 equity shares of face value Re 1 each will be listed and admitted to trading on the National Stock Exchange of India with effect from January 6, 2026.
The equity shares will trade under the symbol ALGOQUANT in the EQ series, marking the company’s formal entry onto the NSE platform alongside its existing presence on the BSE.

Key Listing Details​

ParticularsDetails
Number of Equity Shares28,10,96,028
Face ValueRe 1 per share
NSE SymbolALGOQUANT
SeriesEQ
Market Lot1
Distinctive Numbers1 to 28,10,96,028
Lock-in StatusNot Applicable
Listing DateJanuary 6, 2026
The listing covers the entire equity share capital of the company, ensuring full tradability of all outstanding shares on the NSE from the effective date.

Strategic Significance​

The NSE listing is expected to enhance Algoquant Fintech’s market visibility, broaden investor reach, and improve liquidity in the company’s equity shares. Presence on both major Indian stock exchanges provides the company with a wider institutional and retail investor base and strengthens its capital market profile.

About the Company​

Algoquant Fintech Limited is a Gujarat-based company with its registered office located at GIFT City, Gandhinagar. The company operates in the fintech and financial services domain and is listed on the BSE under the scrip code 505725. With the NSE listing, Algoquant Fintech expands its footprint across India’s leading stock exchanges, supporting its long-term growth and capital market strategy.

Source:
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Back
Top